The U.S. Food and Drug Administration (FDA) has alerted healthcare professionals not to use certain intravenous bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. The FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Foreign matter should not be present in a sterile injectable product. Potentially affected products are sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Healthcare professionals should NOT use and should immediately remove from their pharmacy inventories any metronidazole, ondansetron, and ciprofloxacin intravenous bags sold under the Claris, Sagent Pharmaceuticals, Pfizer and West-Ward Pharmaceutical labels.
For additional information as it becomes available, please visit the FDA website.
Health professionals may report adverse events by using FDA's MedWatch Voluntary Reporting System. Information on how to report is available here.
What's New. . . . .
Contaminated IV Bags of Metronidazole, Ondansetron, and Ciprofloxacin